Ceribell CFO sells 34,502 shares after option exercise
Ceribell, Inc. (CBLL) reported insider transactions by Chief Financial Officer Scott Blumberg on August 18–19, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ceribell, Inc. (CBLL) reported insider transactions by Chief Financial Officer Scott Blumberg on August 18–19, 2026. Blumberg exercised stock options covering 34,502 shares of common stock at exercise prices of $4.70 and $9.41 per share, then sold 34,502 shares of common stock at prices around $25 per share, including a weighted average sale price of $25.03. All transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2025.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F4 | 6,179 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F1, F5 | 27,333 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 6,179 | $4.70 | $29K |
| Exercise | Common Stock F1 | 27,333 | $9.41 | $257K |
| Sale | Common Stock F1, F3 | 33,512 | $25.03 | $839K |
| Exercise | Stock Option (Right to Buy) F1, F4 | 690 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F1, F5 | 300 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 690 | $4.70 | $3K |
| Exercise | Common Stock F1 | 300 | $9.41 | $3K |
| Sale | Common Stock F1 | 990 | $25.00 | $25K |
Footnotes (5)
- F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
- F2. Includes 438 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2026.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25 to $25.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
- F4. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
- F5. The stock option is fully vested and currently exercisable.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Employee Stock Purchase Plan financial
vests financial
stock option financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Ceribell (CBLL) report for CFO Scott Blumberg?
What stock options did the Ceribell (CBLL) CFO exercise in this Form 4?
Were the Ceribell (CBLL) insider transactions under a Rule 10b5-1 plan?
Did the Ceribell (CBLL) filing mention any Employee Stock Purchase Plan activity?
AI-generated analysis. How Rhea-AI works. Not financial advice.